Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105534 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
A Phase 3 study of Bacterial Conjunctivitis, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- Phase 3
- Development phase
- 685
- Enrollment target
- 20
- Study locations
NCT00105534 is a Phase 3 study of Bacterial Conjunctivitis that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 685 participants, above the 527-participant average among 7 other Bacterial Conjunctivitis trials with a reported enrollment target (30% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT00105534, a Phase 3 study of Bacterial Conjunctivitis, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 685 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the clinical and microbial efficacy and safety of AzaSite compared to vehicle for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye may be eligible. Subjects will be randomly assigned to receive either 1.0 % AzaSite or Vehicle. Three visits will be required for this study.
Conditions Studied
Interventions
- OTHER Vehicle
- DRUG AzaSite
Study Locations (20)
California
- Rx For Life, Inc. - Cudahy
- North Bay Eye Associates - Petaluma and Santa Rosa
- San Diego Eye and Laser Center - San Diego
Louisiana
- Bossier Optical Inc. - Bossier City
- Bohn and Joseph Eye Center - Lafayette
- The Louisiana Eye Center - Zachary
North Carolina
- Charlotte Eye, Ear, Nose, and Throat - Charlotte
- Horizon Eye Center - Charlotte
- Groat Eyecare Associates - Greensboro
New Jersey
- Clinical Research Laboratories - Piscataway
- Advanced Eyecare and Laser Center - Runnemede
Arizona
- I Care! Eye Care! - Flagstaff
Colorado
- Western States Clinical Research - Wheat Ridge
Connecticut
- Opticare Eye Health Center - Waterbury
Florida
- International Eye Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 685 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00105534
The ClinicalTrials.gov registry entry for NCT00105534 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 685 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 527-participant average among 7 other Bacterial Conjunctivitis trials with a reported enrollment target (30% higher). The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Conjunctivitis appearing as the primary indexed condition, and to 2 interventions - of which Vehicle is the first listed.
NCT00105534 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Louisiana, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00105534 about?
NCT00105534 is a clinical study titled "Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)". The purpose of this study is to evaluate the clinical and microbial efficacy and safety of AzaSite compared to vehicle for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye may be eligible. Subjects will be randomly assigned to ...
What is the current status of trial NCT00105534?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 685 participants. The study started on 2004-07. Estimated completion is 2006-01.
What conditions does trial NCT00105534 study?
This clinical trial studies the following conditions: Bacterial Conjunctivitis.
What interventions are being tested in trial NCT00105534?
The interventions under investigation include: Vehicle (OTHER), AzaSite (DRUG).
Who is sponsoring clinical trial NCT00105534?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00105534 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Conjunctivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
RECRUITING · Phase 3
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
COMPLETED · Phase 3
-
AL-15469A for the Treatment of Bacterial Conjunctivitis
COMPLETED · Phase 3
-
AL-15469A for the Treatment of Bacterial Conjunctivitis
COMPLETED · Phase 3
-
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
COMPLETED · Phase 3
-
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.